Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.520
-0.050 (-3.18%)
Feb 11, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Ionis
21.92M
Ionis Growth
19466.96%
Moderna
18.12M
Moderna Growth
24.80%
Affini-T
4.72M
Affini-T Growth
83.74%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
44.76M
United States Growth
160.21%